Disperse azo dyes, arylamines and halogenated dinitrobenzene compounds in synthetic garments on the Swedish market.


Journal

Contact dermatitis
ISSN: 1600-0536
Titre abrégé: Contact Dermatitis
Pays: England
ID NLM: 7604950

Informations de publication

Date de publication:
Oct 2022
Historique:
revised: 02 05 2022
received: 15 03 2022
accepted: 20 05 2022
pubmed: 26 5 2022
medline: 9 9 2022
entrez: 25 5 2022
Statut: ppublish

Résumé

Azobenzene disperse dyes (azo DDs) are well-known as textile allergens, but the knowledge of their occurrence in garments is low. The numerous azo DDs and dye components found in textiles constitute a potential health risk, but only seven azo DDs are included in the European baseline patch test series (EBS). To investigate non-regulated azo DDs and dye components in synthetic garments on the Swedish market. High-performance liquid chromatography/mass spectrometry, gas chromatography/mass spectrometry and computerized data mining. Sixty-two azo DDs were detected, with Disperse Red 167:1 occurring in 67%, and 14 other DDs each found in >20% of the garments. Notably, the EBS dyes were less common, three even not detected, while arylamines were frequently detected and exceeded 1 mg/g in several garments. Also, halogenated dinitrobenzenes were identified in 25% of the textiles. Azo DDs and dye components, in complex compositions and with large variations, occurred frequently in the synthetic garments. The arylamines were shown to occur at much higher levels compared to the azo DDs, suggesting the former constitute a potentially higher health risk. The role of arylamines and halogenated dinitrobenzenes in textile allergy has to be further investigated.

Sections du résumé

BACKGROUND BACKGROUND
Azobenzene disperse dyes (azo DDs) are well-known as textile allergens, but the knowledge of their occurrence in garments is low. The numerous azo DDs and dye components found in textiles constitute a potential health risk, but only seven azo DDs are included in the European baseline patch test series (EBS).
OBJECTIVES OBJECTIVE
To investigate non-regulated azo DDs and dye components in synthetic garments on the Swedish market.
METHODS METHODS
High-performance liquid chromatography/mass spectrometry, gas chromatography/mass spectrometry and computerized data mining.
RESULTS RESULTS
Sixty-two azo DDs were detected, with Disperse Red 167:1 occurring in 67%, and 14 other DDs each found in >20% of the garments. Notably, the EBS dyes were less common, three even not detected, while arylamines were frequently detected and exceeded 1 mg/g in several garments. Also, halogenated dinitrobenzenes were identified in 25% of the textiles.
CONCLUSION CONCLUSIONS
Azo DDs and dye components, in complex compositions and with large variations, occurred frequently in the synthetic garments. The arylamines were shown to occur at much higher levels compared to the azo DDs, suggesting the former constitute a potentially higher health risk. The role of arylamines and halogenated dinitrobenzenes in textile allergy has to be further investigated.

Identifiants

pubmed: 35611449
doi: 10.1111/cod.14163
pmc: PMC9542814
doi:

Substances chimiques

Allergens 0
Amines 0
Azo Compounds 0
Coloring Agents 0
Dinitrobenzenes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

315-324

Subventions

Organisme : Naturvårdsverket
ID : 2219-17-009
Organisme : Stiftelsen för Miljöstrategisk Forskning
Organisme : Svenska Forskningsrådet Formas
Organisme : Swedish Asthma and Allergy Association
ID : F2019-0018
Organisme : FORMAS
ID : 2021-01540
Organisme : FORMAS
ID : 2017-01532
Organisme : Swedish Foundation for Strategic Environmental Research
ID : 2018/11

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2022 The Authors. Contact Dermatitis published by John Wiley & Sons Ltd.

Références

Regul Toxicol Pharmacol. 2017 Aug;88:214-226
pubmed: 28655654
Exp Dermatol. 2009 Sep;18(9):789-92
pubmed: 19397699
Am J Contact Dermat. 2002 Sep;13(3):101-7
pubmed: 12165928
J Environ Sci Health A Tox Hazard Subst Environ Eng. 2016 Jul 28;51(9):744-53
pubmed: 27149414
Contact Dermatitis. 2014 Oct;71(4):215-23
pubmed: 24815318
Contact Dermatitis. 2015 Jul;73(1):15-20
pubmed: 25925831
Contact Dermatitis. 1998 Jun;38(6):332-6
pubmed: 9687033
Hum Exp Toxicol. 1999 Sep;18(9):552-9
pubmed: 10523869
Contact Dermatitis. 1997 Feb;36(2):91-6
pubmed: 9062744
Contact Dermatitis. 2013 Feb;68(2):65-75
pubmed: 23289879
Anal Bioanal Chem. 2022 Jan;414(3):1403-1413
pubmed: 34786606
Regul Toxicol Pharmacol. 2014 Jul;69(2):263-72
pubmed: 24793261
Contact Dermatitis. 2006 Jun;54(6):313-21
pubmed: 16787452
Contact Dermatitis. 2009 May;60(5):270-8
pubmed: 19397619
Acta Derm Venereol. 2015 Apr;95(4):427-31
pubmed: 25166030
Contact Dermatitis. 2011 Jul;65(1):38-42
pubmed: 21309788
Contact Dermatitis. 2008 Apr;58(4):199-209
pubmed: 18353027
J Chromatogr A. 2016 Nov 4;1471:11-18
pubmed: 27745926
J Chromatogr A. 2019 May 10;1592:71-81
pubmed: 30665740
J Med Microbiol. 2010 Jan;59(Pt 1):108-114
pubmed: 19729456
Front Biosci (Elite Ed). 2010 Jun 01;2(3):1169-83
pubmed: 20515789
Environ Pollut. 2021 Oct 15;287:117299
pubmed: 34023658
Contact Dermatitis. 2022 Oct;87(4):315-324
pubmed: 35611449
Contact Dermatitis. 2012 Sep;67(3):141-8
pubmed: 22748162
Dermatitis. 2011 Nov-Dec;22(6):335-43
pubmed: 22653007
Contact Dermatitis. 2019 Jan;80(1):1-4
pubmed: 30421432

Auteurs

Josefine Carlsson (J)

Department of Materials and Environmental Chemistry, Stockholm University, Stockholm, Sweden.

Tim Åström (T)

Department of Materials and Environmental Chemistry, Stockholm University, Stockholm, Sweden.

Conny Östman (C)

Department of Materials and Environmental Chemistry, Stockholm University, Stockholm, Sweden.

Ulrika Nilsson (U)

Department of Materials and Environmental Chemistry, Stockholm University, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH